射频肾去神经术治疗高危难治性高血压的单中心初步结果
该前瞻性单中心观察研究纳入18例难治性高血压患者,均在最大耐受剂量下使用至少3种降压药后诊室收缩压仍>155 mmHg、舒张压>90 mmHg。患者接受Symplicity Spyral系统双侧射频肾去神经术,术后72小时和1个月评估疗效与安全性。结果显示大多数患者获得早期临床应答,围手术期并发症包括肾动脉夹层、股动脉夹层穿孔等。
要点
- 难治性高血压患者在多药最大耐受剂量下血压仍不达标时,可考虑射频肾去神经术作为辅助治疗。
- 术后72小时至1个月多数患者出现早期血压应答,部分患者可减少降压药数量或剂量。
- 围手术期需警惕肾动脉夹层、股动脉夹层穿孔及穿刺部位血肿等血管并发症。
核心结论
- 射频肾去神经术在该高危真实世界难治性高血压人群中技术上可行,多数患者术后出现早期临床应答。
研究设计与样本
- 前瞻性、观察性、单中心研究,纳入18例接受Symplicity Spyral系统双侧射频肾去神经术的难治性高血压患者。
- 入选标准为基线诊室收缩压>155 mmHg且舒张压>90 mmHg,尽管已使用至少3种最大耐受剂量降压药。
主要发现
- 所有手术均技术成功。术后72小时内15例(83.3%)同时满足诊室收缩压下降≥10 mmHg和24小时动态收缩压下降≥5 mmHg两条应答标准。
- 术后1个月时16例(88.9%)为应答者,2例(11.1%)为无应答者。
- 应答者中5例停用1种降压药并继续双联治疗,11例继续三联治疗但剂量降低。
- 围手术期事件包括1例医源性肾动脉夹层、1例股动脉夹层伴穿孔、1例导丝断裂并经血管内抓捕器成功取出、2例股部血肿。
- 肾功能未见恶化。
关键数值与推荐
- 临床应答需同时满足诊室收缩压下降≥10 mmHg和24小时平均动态收缩压下降≥5 mmHg。
- 术后72小时所有应答者诊室收缩压下降幅度均≥20 mmHg。
临床怎么用
- 对于多药最大耐受剂量下血压仍明显升高的难治性高血压患者,射频肾去神经术可作为一种辅助治疗选择。
- 术后早期应答者可能实现降压药减量或减品种。
- 操作过程中和术后需密切监测血管入路及肾动脉相关并发症。
局限性
- 样本量小、随访时间短且缺乏对照组,无法得出确切的疗效结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Renal denervation (RDN) is an adjunctive treatment for selected patients with resistant hypertension. We report the preliminary effectiveness and safety of radiofrequency RDN in a high-risk real-world population. This prospective, observational, single-center study enrolled 18 patients who underwent bilateral RDN using the Symplicity Spyral system. All had baseline office systolic BP (SBP) > 155 mmHg and diastolic BP > 90 mmHg despite at least three antihypertensive drugs at the maximum tolerated doses. Clinical response required both an office SBP reduction ≥ 10 mm Hg and a mean 24-h ambulatory SBP reduction ≥ 5 mm Hg. Outcomes were assessed within 72 h and at 1 month. All procedures were technically successful. At 72 h, 15 patients (83.3%) met both response criteria; all had an office SBP reduction ≥ 20 mm Hg. At 1 month, 16 (88.9%) were responders and 2 (11.1%) were nonresponders. Among responders, five discontinued one drug and continued dual therapy, whereas 11 continued three drugs at reduced doses. Procedural events included one iatrogenic renal artery dissection, one femoral artery dissection with perforation, one guidewire fracture successfully retrieved with an endovascular snare, and two femoral hematomas. Renal function did not deteriorate. In conclusion, radiofrequency RDN was technically feasible and was followed by an early clinical response in most patients. The small sample, short follow-up, and absence of a control group preclude definitive efficacy conclusions.
引用
- Catheterization and Cardiovascular Interventions:Percutaneous Renal Denervation for Resistant Hypertension in a High‐Risk Real‐World Population: Preliminary Results From a Prospective Single‐Center Experience
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。